GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Price-to-Operating-Cash-Flow

ArcticZymes Technologies ASA (FRA:B4V) Price-to-Operating-Cash-Flow : 176.88 (As of May. 22, 2025)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Price-to-Operating-Cash-Flow?

As of today (2025-05-22), ArcticZymes Technologies ASA's share price is €1.415. ArcticZymes Technologies ASA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was €0.01. Hence, ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow Ratio for today is 176.88.

The historical rank and industry rank for ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:B4V' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 31.78   Med: 65.1   Max: 1076
Current: 171.43

During the past 13 years, ArcticZymes Technologies ASA's highest Price-to-Operating-Cash-Flow Ratio was 1076.00. The lowest was 31.78. And the median was 65.10.

FRA:B4V's Price-to-Operating-Cash-Flow is ranked worse than
90.79% of 304 companies
in the Biotechnology industry
Industry Median: 24.695 vs FRA:B4V: 171.43

ArcticZymes Technologies ASA's Cash Flow from Operations per share for the three months ended in Mar. 2025 was €-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was €0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of ArcticZymes Technologies ASA was -82.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -72.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -17.80% per year.

During the past 13 years, ArcticZymes Technologies ASA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 140.90% per year. The lowest was -278.50% per year. And the median was -4.40% per year.


ArcticZymes Technologies ASA Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Price-to-Operating-Cash-Flow Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.81 62.75 62.52 87.32 404.24

ArcticZymes Technologies ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.75 62.19 122.19 404.24 175.51

Competitive Comparison of ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow falls into.


;
;

ArcticZymes Technologies ASA Price-to-Operating-Cash-Flow Calculation

ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.415/0.008
=176.88

ArcticZymes Technologies ASA's Share Price of today is €1.415.
ArcticZymes Technologies ASA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

ArcticZymes Technologies ASA Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines